Abstract:ABSTRACT Viruses can modify conditions inside cells to make them more favorable for replication and progeny virus production. One way of doing this is through manipulation of the cell cycle, a process that describes the ordered growth and division of cells. Analysis of model cell lines, such as A549 cells and primary airway epithelial cells, infected with human respiratory syncytial virus (HRSV) has shown alteration of the cell cycle during infection, although the signaling events were not clearly understood. In this study, targeted transcriptomic analysis of HRSV-infected primary airway epithelial cells revealed alterations in the abundances of many mRNAs encoding cell cycle-regulatory molecules, including decreases in the D-type cyclins and corresponding cyclin-dependent kinases (CDK4 and CDK6 [CDK4/6]). These alterations were reflected in changes in protein abundance and/or relocalization in HRSV-infected cells; taken together, they were predicted to result in G 0 /G 1 phase arrest. In contrast, there was no change in the abundances of D-type cyclins in A549 cells infected with HRSV. However, the abundance of the G 1 /S phase progression inhibitor p21 WAF1/CIP1 was increased over that in mock-treated cells, and this, again, was predicted to result in G 0 /G 1 phase arrest. The G 0 /G 1 phase arrest in both HRSV-infected primary cells and A549 cells was confirmed using dual-label flow cytometry that accurately measured the different stages of the cell cycle. Comparison of progeny virus production in primary and A549 cells enriched in G 0 /G 1 using a specific CDK4/6 kinase inhibitor with asynchronously replicating cells indicated that this phase of the cell cycle was more efficient for virus production.

P53-Independent G1-Cell Cycle Arrest Increases SARS-CoV-2 RNA Replication

GCG inhibits SARS-CoV-2 replication by disrupting the liquid phase condensation of its nucleocapsid protein

Host Cell Cycle Checkpoint As Antiviral Target for SARS-CoV-2 Revealed by Integrative Transcriptome and Proteome Analyses

SARS-CoV-2 Nucleocapsid Protein Impairs SG Assembly by Partitioning into G3BP Condensate

Involvement of miR-15a in G0/G1 Phase Cell Cycle Arrest Induced by Porcine Circovirus Type 2 Replication

P53 Signaling Modulation of Cell Cycle Arrest and Viral Replication in Porcine Circovirus Type 2 Infection Cells

Porcine Epidemic Diarrhea Virus Through P53-Dependent Pathway Causes Cell Cycle Arrest in the G0/G1 Phase

Global siRNA Screen Reveals Critical Human Host Factors of SARS-CoV-2 Multicycle Replication

Influenza A Virus NS1 Induces G0/G1 Cell Cycle Arrest by Inhibiting the Expression and Activity of RhoA Protein.

Influenza A Virus Replication Induces Cell Cycle Arrest in G <sub>0</sub> /G <sub>1</sub> Phase

Quinoline and Quinazoline Derivatives Inhibit Viral RNA Synthesis by SARS-CoV-2 RdRp

Targeting RNA G-quadruplex with repurposed drugs blocks SARS-CoV-2 entry

SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis

Signaling Pathway Reporter Screen with SARS-CoV-2 Proteins Identifies nsp5 as a Repressor of p53 Activity

Porcine Reproductive and Respiratory Syndrome Virus Inhibits MARC-145 Proliferation Via Inducing Apoptosis and G2/M Arrest by Activation of Chk/Cdc25C and P53/p21 Pathway.

Assessing the inhibitory effects of some secondary amines, thioureas and 1,3-dimethyluracil conjugates of (-)-cytisine and thermopsine on the RNA-dependent RNA polymerase of SARS-CoV-1 and SARS-CoV-2

TMPRSS2 isoform 1 downregulation by G-quadruplex stabilization induces SARS-CoV-2 replication arrest

Influenza A virus replication induces cell cycle arrest in G0/G1 phase.

PACT Inhibits the Replication of SARS-CoV-2 Through the Blockage of GSK-3β-N-nsp3 Cascade.

Characterization of the Interaction between Human Respiratory Syncytial Virus and the Cell Cycle in Continuous Cell Culture and Primary Human Airway Epithelial Cells

Novel Tetrahydroisoquinoline-Based Heterocyclic Compounds Efficiently Inhibit SARS-CoV-2 Infection In Vitro